Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AR › Little Rock › NPI 1780684431
Hospital

ST Vincent Infirmary Medical Center

ST Vincent Infirmary Medical Center was paid $8.31M by Medicaid between Jan 2018 and Dec 2024, across 239 billing codes. Its largest line is 11042, Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm — 11% of everything it billed.

33Billing provider infoST VINCENT INFIRMARY MEDICAL CENTER
LITTLE ROCK, AR 72205
33aNPI1780684431assigned 07/22/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.31M
24GClaims688,588
24DCodes billed239
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Arkansas

Rank by total paid#11 of 49
Median peer was paid$2.62M
This provider vs. median3.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018113,942$1.22M
2019132,444$1.41M
202094,929$1.07M
202189,878$1.16M
202294,624$1.40M
202397,314$1.31M
2024incomplete65,457$751K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 11% 8,448 3,611 $913K
74177 Computed tomography, abdomen and pelvis; with contrast material 5.9% 4,865 3,962 $490K
70450 Computed tomography, head or brain; without contrast material 5.4% 5,829 4,787 $445K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4.9% 6,982 5,623 $406K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.8% 44,182 31,642 $312K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 3.6% 3,664 2,915 $297K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 3.3% 1,782 1,508 $278K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.1% 5,844 3,437 $258K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.5% 3,602 3,026 $204K
80053 Comprehensive metabolic panel 2.4% 25,479 19,969 $202K
72125 Computed tomography, cervical spine; without contrast material 2.2% 1,874 1,561 $181K
36415 Collection of venous blood by venipuncture 2.0% 24,280 18,419 $166K
227 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.0% 2,393 $165K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.8% 19,014 $149K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.7% 2,573 $142K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 22,256 $130K
C1769 Guide wire 1.5% 1,788 $128K
80048 Basic metabolic panel (calcium, ionized) 1.4% 23,273 $115K
96375 Therapeutic injection; each additional sequential IV push 1.3% 7,917 $111K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.3% 2,996 $110K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.3% 2,988 $108K
83880 1.3% 4,420 $107K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.2% 5,560 $99K
71275 Computed tomographic angiography, chest, with contrast material 1.1% 769 $95K
84484 1.1% 11,781 $92K
71046 Radiologic examination, chest; 2 views 1.0% 6,414 $85K
83690 1.0% 9,745 $84K
81025 <1% 10,838 $83K
83735 <1% 9,762 $79K
99283 Emergency room visit (moderate) <1% 4,911 $77K
81001 <1% 14,123 $72K
59025 Fetal non-stress test <1% 427 $71K
29581 <1% 1,904 $70K
99284 Emergency room visit (serious) <1% 7,596 $68K
71045 Radiologic examination, chest; single view <1% 10,540 $67K
86901 <1% 4,584 $63K
80047 <1% 6,468 $61K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 721 $61K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 6,456 $60K
82962 <1% 14,007 $60K
99285 Emergency room visit (most serious) <1% 6,815 $54K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,845 $47K
83605 <1% 3,937 $46K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 673 $45K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 3,915 $42K
80061 Lipid panel <1% 3,369 $42K
83036 Hemoglobin; glycosylated (A1C) <1% 7,542 $41K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,735 $39K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,199 $36K
93296 <1% 4,422 $35K
87077 <1% 3,701 $35K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 21,419 $33K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 10,045 $33K
81003 <1% 9,443 $32K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 387 $32K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,104 $32K
96361 Intravenous infusion, hydration; each additional hour <1% 2,722 $31K
85610 <1% 14,629 $31K
84443 Thyroid stimulating hormone (TSH) <1% 4,204 $30K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 170 $29K
82550 <1% 2,655 $27K
80076 <1% 2,794 $27K
73564 <1% 913 $25K
87070 <1% 2,287 $25K
80320 <1% 2,049 $24K
85730 <1% 7,422 $23K
70551 Magnetic resonance imaging, brain; without contrast material <1% 125 $22K
86850 <1% 3,967 $21K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,522 $21K
87040 <1% 3,114 $21K
82565 <1% 1,713 $19K
72131 <1% 212 $19K
36430 <1% 282 $18K
80050 General health panel <1% 389 $17K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,974 $17K
85379 <1% 2,272 $17K
93458 <1% 585 $17K
96376 <1% 2,777 $15K
84145 <1% 1,269 $15K
87430 <1% 1,380 $14K
85027 <1% 2,852 $12K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 400 $12K
86900 <1% 4,584 $12K
82553 <1% 1,725 $11K
87210 <1% 2,808 $11K
93017 <1% 1,950 $11K
73030 <1% 558 $11K
87081 <1% 1,631 $11K
87186 <1% 2,881 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,882 $10K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 72 $10K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 794 $10K
71250 <1% 126 $9K
84702 <1% 967 $9K
80074 <1% 264 $9K
85014 <1% 8,346 $9K
73630 <1% 328 $8K
J1650 Injection, enoxaparin sodium, 10 mg <1% 988 $8K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 702 $8K
76801 <1% 242 $8K
A9576 Injection, gadoteridol, (prohance multipack), per ml <1% 554 $7K
87205 <1% 2,868 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,919 $7K
80329 <1% 741 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 6,773 $6K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 32 $6K
90715 <1% 327 $6K
73610 <1% 279 $5K
70486 <1% 43 $5K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,323 $5K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 216 $5K
86703 <1% 401 $5K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 646 $5K
84703 <1% 561 $5K
84439 <1% 995 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 9,619 $4K
82607 <1% 482 $4K
93880 <1% 230 $3K
J2785 Injection, regadenoson, 0.1 mg <1% 1,575 $3K
86780 <1% 232 $3K
70496 <1% 46 $3K
70498 <1% 39 $3K
72110 <1% 107 $3K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 4,218 $3K
A9270 Non-covered item or service <1% 17,275 $3K
72141 <1% 15 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 13,041 $3K
84132 <1% 1,447 $3K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 110 $3K
84481 <1% 395 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 7,270 $3K
J1750 Injection, iron dextran, 50 mg <1% 18 $3K
88342 <1% 220 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,123 $2K
84100 <1% 809 $2K
82947 <1% 1,242 $2K
93280 <1% 810 $2K
J1815 Injection, insulin, per 5 units <1% 756 $2K
85049 <1% 627 $2K
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries <1% 127 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 52 $2K
97162 <1% 124 $2K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 182 $2K
73130 <1% 80 $2K
76937 <1% 620 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,955 $2K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,065 $2K
11045 <1% 238 $2K
74018 <1% 180 $1K
J2060 Injection, lorazepam, 2 mg <1% 2,113 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,100 $1K
82803 <1% 74 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 5,974 $1K
82746 <1% 167 $1K
96367 <1% 32 $1K
87428 <1% 42 $1K
72100 <1% 95 $1K
73502 <1% 62 $1K
78803 <1% 14 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 378 $965.07
85045 <1% 459 $964.60
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,390 $954.42
83525 <1% 84 $874.96
97597 <1% 92 $839.34
82010 <1% 16 $832.89
J1170 Injection, hydromorphone, up to 4 mg <1% 7,888 $832.77
93971 <1% 55 $829.92
J2704 Injection, propofol, 10 mg <1% 5,014 $828.36
83550 <1% 177 $754.42
83540 <1% 251 $753.71
86923 <1% 269 $746.64
93970 <1% 50 $728.89
J1630 Injection, haloperidol, up to 5 mg <1% 512 $696.52
82728 <1% 76 $633.54
78306 <1% 13 $584.52
36600 <1% 37 $562.96
J1956 Injection, levofloxacin, 250 mg <1% 649 $552.56
97001 <1% 60 $494.40
88304 <1% 19 $484.58
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 32 $481.47
85651 <1% 212 $466.03
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,708 $465.99
J3480 Injection, potassium chloride, per 2 meq <1% 484 $409.95
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,611 $346.83
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,585 $309.94
85347 <1% 338 $306.87
87340 <1% 28 $298.98
90686 <1% 57 $283.10
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 15 $275.18
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 2,362 $267.31
94729 <1% 18 $241.00
87075 <1% 94 $236.56
76376 <1% 30 $229.04
94726 <1% 18 $221.10
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 26 $205.94
J3370 Injection, vancomycin hcl, 500 mg <1% 255 $203.14
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 1,484 $201.65
93321 <1% 94 $200.26
82270 <1% 23 $184.40
82951 <1% 14 $183.90
82043 <1% 87 $181.16
84480 <1% 43 $162.00
87045 <1% 13 $148.17
84550 <1% 69 $141.24
81015 <1% 372 $138.61
93356 <1% 68 $137.73
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 15 $135.69
93325 <1% 136 $132.32
76000 <1% 251 $129.47
93290 <1% 12 $115.24
J1790 Injection, droperidol, up to 5 mg <1% 648 $113.91
82570 <1% 51 $103.46
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 31 $100.68
J0360 Injection, hydralazine hcl, up to 20 mg <1% 752 $95.46
87102 <1% 51 $87.24
J1940 Injection, furosemide, up to 20 mg <1% 1,323 $86.80
87116 <1% 16 $81.32
J2550 Injection, promethazine hcl, up to 50 mg <1% 454 $54.40
93283 <1% 42 $46.43
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 322 $40.79
87206 <1% 15 $40.42
87046 <1% 13 $37.07
86140 <1% 12 $29.56
76942 <1% 30 $16.75
G0378 Hospital observation service, per hour <1% 2,427 $7.91
89051 <1% 17 $7.86
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 101 $4.38
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 135 $0.92
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 104 $0.01
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 103 $0.01
36416 0% 122 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 61 $0.00
99213 Doctor's office visit, returning patient (routine) 0% 57 $0.00
G0008 Administration of influenza virus vaccine 0% 104 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 412 $0.00
P9016 Red blood cells, leukocytes reduced, each unit 0% 19 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 198 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 43 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 70 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSZOSTEK, JOSHUA (VP OPERATIONAL FINANCE)
Same official

Other billing entities under SZOSTEK, JOSHUA

Full network →
ProviderLocationPaid
Chi ST Vincent Hospital Hot SpringsHot Springs, AR$16.38M
ST. Vincent Infirmary Medical CenterSherwood, AR$2.98M
Chi ST Vincent Hospital Hot SpringsHot Springs, AR$236K
ST. Vincent Infirmary Medical CenterLittle Rock, AR$121K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.